JFS Wealth Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

JFS Wealth Advisors’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-500	Closed	-$2K	–	616
2020 Q4	$2K	Hold	500	–	–	﹤0.01%	536
2020 Q3	$1K	Hold	500	–	–	﹤0.01%	539
2020 Q2	$2K	Hold	500	–	–	﹤0.01%	494
2020 Q1	$2K	Hold	500	–	–	﹤0.01%	446
2019 Q4	$3K	Hold	500	–	–	﹤0.01%	434
2019 Q3	$2K	Hold	500	–	–	﹤0.01%	453
2019 Q2	$2K	Hold	500	–	–	﹤0.01%	437
2019 Q1	$2K	Hold	500	–	–	﹤0.01%	440
2018 Q4	$2K	Hold	500	–	–	﹤0.01%	426
2018 Q3	$2K	Hold	500	–	–	﹤0.01%	497
2018 Q2	$4K	Hold	500	–	–	﹤0.01%	414
2018 Q1	$3K	Hold	500	–	–	﹤0.01%	460
2017 Q4	$5K	Hold	500	–	–	﹤0.01%	431
2017 Q3	$5K	Sell	500 -500	-50%	-$4.31K	﹤0.01%	395
2017 Q2	$8K	Hold	1,000	–	–	﹤0.01%	353
2017 Q1	$6K	Hold	1,000	–	–	﹤0.01%	384
2016 Q4	$6K	Hold	1,000	–	–	﹤0.01%	384
2016 Q3	$7K	Hold	1,000	–	–	﹤0.01%	411
2016 Q2	$8K	Hold	1,000	–	–	﹤0.01%	404
2016 Q1	$7K	Hold	1,000	–	–	﹤0.01%	429
2015 Q4	$9K	Hold	1,000	–	–	﹤0.01%	404
2015 Q3	$5K	Buy	+1,000	New	+$6.29K	﹤0.01%	391

Other funds holding ORMP

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FWM

Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

JFS Wealth Advisors's ORMP Position: Q1 2021 in Review

JFS Wealth Advisors sold out of Oramed Pharmaceuticals (ORMP) in Q1 2021, closing a stake of 500 shares — an estimated $2K sold.

JFS Wealth Advisors first reported a position in ORMP in Q3 2015 and held it in 22 quarters. The position peaked at $9K in Q4 2015. 44 funds tracked by Wall St. Rank hold ORMP as of Q1 2021.

JFS Wealth Advisors reported no remaining Oramed Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
JFS Wealth Advisors sold 500 Oramed Pharmaceuticals shares in Q1 2021, an estimated $2K.
JFS Wealth Advisors first reported a position in Oramed Pharmaceuticals in Q3 2015 and held it in 22 quarters.
JFS Wealth Advisors's Oramed Pharmaceuticals position peaked at $9K in Q4 2015.
44 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2021.

Based on JFS Wealth Advisors's 13F filing for Q1 2021, filed 28 Apr 2021.